{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:59:57Z","timestamp":1791417597995,"version":"4.3.3"},"reference-count":158,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological Psychiatry"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.biopsych.2004.12.006","type":"journal-article","created":{"date-parts":[[2005,1,29]],"date-time":"2005-01-29T07:22:16Z","timestamp":1106983336000},"page":"594-608","source":"Crossref","is-referenced-by-count":512,"title":["Delta-9-tetrahydrocannabinol effects in schizophrenia: Implications for cognition, psychosis, and addiction"],"prefix":"10.1016","volume":"57","author":[{"given":"Deepak Cyril","family":"D\u2019Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walid Michel","family":"Abi-Saab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Madonick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberlee","family":"Forselius-Bielen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Doersch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Braley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralitza","family":"Gueorguieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John Harrison","family":"Krystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/j.biopsych.2004.12.006_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1017\/S1461145704004110","article-title":"Do we still believe in the dopamine hypothesis? New data bring new evidence","volume":"7","author":"Abi-Dargham","year":"2004","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib2","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1176\/ajp.155.6.761","article-title":"Increased striatal dopamine transmission in schizophrenia","volume":"155","author":"Abi-Dargham","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib3","doi-asserted-by":"crossref","first-page":"3708","DOI":"10.1523\/JNEUROSCI.22-09-03708.2002","article-title":"Prefrontal dopamine D1 receptors and working memory in schizophrenia","volume":"22","author":"Abi-Dargham","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0165-6147(92)90064-D","article-title":"Neurobiology of marijuana abuse","volume":"13","author":"Abood","year":"1992","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib5","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1111\/j.1360-0443.1996.tb02264.x","article-title":"Cannabis","volume":"91","author":"Adams","year":"1996","journal-title":"Addiction"},{"key":"10.1016\/j.biopsych.2004.12.006_bib6","first-page":"99","article-title":"Substance abuse and cognitive functioning in schizophrenia [comment]","volume":"22","author":"Addington","year":"1997","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1600-0447.1997.tb09925.x","article-title":"Reasons for substance use in schizophrenia","volume":"96","author":"Addington","year":"1997","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.biopsych.2004.12.006_bib8","first-page":"21","article-title":"Pharmacokinetics and metabolism of delta 1-tetrahydrocannabinol and other cannabinoids with emphasis on man","volume":"38","author":"Agurell","year":"1986","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2004.12.006_bib9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/02791072.1998.10399692","article-title":"High resolution brain SPECT imaging of marijuana smokers with AD\/HD","volume":"30","author":"Amen","year":"1998","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.biopsych.2004.12.006_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(87)92620-1","article-title":"Cannabis and schizophrenia. A longitudinal study of Swedish conscripts","volume":"2","author":"Andreasson","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2004.12.006_bib11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/S0140-6736(88)91823-5","article-title":"Cannabis and schizophrenia","volume":"1","author":"Andreasson","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.biopsych.2004.12.006_bib12","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1136\/bmj.325.7374.1212","article-title":"Cannabis use in adolescence and risk for adult psychosis","volume":"325","author":"Arseneault","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2004.12.006_bib13","first-page":"114","article-title":"Marijuana smoking","volume":"261","author":"Azorlosa","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2004.12.006_bib14","first-page":"74","article-title":"Cannabinoids","volume":"194","author":"Banerjee","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2004.12.006_bib15","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1192\/bjp.154.5.672","article-title":"A rating scale for drug-induced akathisia","volume":"154","author":"Barnes","year":"1989","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/BF00426745","article-title":"A comparison of some pharmacological actions of morphine and delta9-tetrahydrocannabinol in the mouse","volume":"57","author":"Bloom","year":"1978","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.biopsych.2004.12.006_bib17","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF02737066","article-title":"Effects of perinatal exposure to delta 9-tetrahydrocannabinol on the fetal and early postnatal development of tyrosine hydroxylase-containing neurons in rat brain","volume":"7","author":"Bonnin","year":"1996","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib18","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0028-3932(67)90015-2","article-title":"Word fluency and brain damage","volume":"5","author":"Borkowski","year":"1967","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.biopsych.2004.12.006_bib19","first-page":"825","article-title":"Effect of cannabidiol pretreatment on the kinetics of tetrahydrocannabinol metabolites in mouse brain","volume":"23","author":"Bornheim","year":"1995","journal-title":"Drug Metab Disposition"},{"key":"10.1016\/j.biopsych.2004.12.006_bib20","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/13854049108403297","article-title":"The Hopkins Verbal Learning Test. Development of a new memory test with 6 equivalent forms","volume":"5","author":"Brandt","year":"1991","journal-title":"Clin Neuropsychol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1023\/A:1024465317902","article-title":"Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)","volume":"11","author":"Bremner","year":"1998","journal-title":"J Trauma Stress"},{"key":"10.1016\/j.biopsych.2004.12.006_bib22","series-title":"Applied Mixed Models in Medicine","author":"Brown","year":"1999"},{"key":"10.1016\/j.biopsych.2004.12.006_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00005053-199701000-00003","article-title":"Relationships between symptoms of schizophrenia and substance abuse","volume":"185","author":"Brunette","year":"1997","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2004.12.006_bib24","series-title":"Nonparametric Analysis of Longitudinal Data in Factorial Experiments","author":"Brunner","year":"2002"},{"key":"10.1016\/j.biopsych.2004.12.006_bib25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/0028-3932(91)90035-7","article-title":"Long-term retention of implicit learning in Huntington\u2019s disease","volume":"29","author":"Bylsma","year":"1991","journal-title":"Neuropsychologia"},{"key":"10.1016\/j.biopsych.2004.12.006_bib26","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1162\/089892900561832","article-title":"Age-related differences in neural activity during item and temporal-order memory retrieval","volume":"12","author":"Cabeza","year":"2000","journal-title":"J Cogn Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib27","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/S0006-3223(99)00194-8","article-title":"The schizophrenia ketamine challenge study debate","volume":"46","author":"Carpenter","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s004060050064","article-title":"Cannabis and schizophrenia","volume":"249","author":"Caspari","year":"1999","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","article-title":"Delta 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis","volume":"102","author":"Chen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/0304-3940(91)90739-G","article-title":"Strain-specific facilitation of dopamine efflux by delta 9-tetrahydrocannabinol in the nucleus accumbens of rat","volume":"129","author":"Chen","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2004.12.006_bib31","first-page":"201","article-title":"Pharmacological profile of a series of bicyclic cannabinoid analogs","volume":"260","author":"Compton","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2004.12.006_bib32","first-page":"112","article-title":"Effects of different cortical excisions on sensory thresholds in man","volume":"89","author":"Corkin","year":"1964","journal-title":"Trans Am Neurol Assoc"},{"key":"10.1016\/j.biopsych.2004.12.006_bib33","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S0006-3223(02)01545-7","article-title":"Cannabis-sensitive dopaminergic markers in postmortem central nervous system","volume":"53","author":"Dean","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib34","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0306-4522(00)00552-2","article-title":"Studies on [3H]CP-55940 binding in the human central nervous system","volume":"103","author":"Dean","year":"2001","journal-title":"Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib35","first-page":"11","article-title":"[Cannabis and schizophrenia","volume":"29","author":"Dervaux","year":"2003","journal-title":"Encephale"},{"key":"10.1016\/j.biopsych.2004.12.006_bib36","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1176\/ajp.148.2.224","article-title":"Drug abuse in schizophrenic patients","volume":"148","author":"Dixon","year":"1991","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib37","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of intravenous Delta-9-tetrahydrocannabinol in healthy individuals","volume":"29","author":"D\u2019Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib38","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/S0006-3223(99)00209-7","article-title":"Symptom provocation studies in psychiatric disorders","volume":"46","author":"D\u2019Souza","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib39","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9861(20000626)422:2<159::AID-CNE1>3.0.CO;2-1","article-title":"Localisation of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB","volume":"422","author":"Egertova","year":"2000","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib40","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1098\/rspb.1998.0543","article-title":"A new perspective on cannabinoid signalling","volume":"265","author":"Egertova","year":"1998","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib41","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1098\/rstb.2000.0787","article-title":"The neurobiology and evolution of cannabinoid signalling","volume":"356","author":"Elphick","year":"2001","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1520\/JFS14636J","article-title":"Potency trends of delta9-THC and other cannabinoids in confiscated marijuana from 1980\u20131997","volume":"45","author":"ElSohly","year":"2000","journal-title":"J Forens Sci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib43","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/S0006-2952(97)00168-8","article-title":"Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion","volume":"53","author":"Fernandez-Ruiz","year":"1997","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/oxfordjournals.schbul.a033339","article-title":"Patterns of current and lifetime substance use in schizophrenia","volume":"24","author":"Fowler","year":"1998","journal-title":"Schizophr Bull"},{"key":"10.1016\/j.biopsych.2004.12.006_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0304-3940(97)00278-4","article-title":"delta9-Tetrahydrocannabinol excites rat VTA dopamine neurons through activation of cannabinoid CB1 but not opioid receptors","volume":"226","author":"French","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.biopsych.2004.12.006_bib46","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00001756-199702100-00014","article-title":"Cannabinoids excite dopamine neurons in the ventral tegmentum and substantia nigra","volume":"8","author":"French","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2004.12.006_bib47","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.biopsych.2004.12.006_bib48","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1042\/bj2790129","article-title":"Molecular cloning of a human cannabinoid receptor which is also expressed in testis","volume":"279","author":"Gerard","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.biopsych.2004.12.006_bib49","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2004.12.006_bib50","first-page":"288","article-title":"Microprocessor-based assessment of attention deficit disorders (ADD)","volume":"22","author":"Gordon","year":"1986","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2004.12.006_bib51","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/10550490490435795","article-title":"Substance-abusing schizophrenics","volume":"13","author":"Goswami","year":"2004","journal-title":"Am J Addict"},{"key":"10.1016\/j.biopsych.2004.12.006_bib52","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.schres.2003.08.001","article-title":"First episode schizophrenia-related psychosis and substance use disorders","volume":"66","author":"Green","year":"2004","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.12.006_bib53","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0306-3623(94)90027-2","article-title":"Anxiolytic effect of cannabidiol derivatives in the elevated plus-maze","volume":"25","author":"Guimaraes","year":"1994","journal-title":"Gen Pharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib54","first-page":"22","article-title":"The incidence of treatment emergent symptoms under chlorpromazine and placebo conditions [proceedings]","volume":"14","author":"Guy","year":"1978","journal-title":"Psychopharmacol Bull"},{"key":"10.1016\/j.biopsych.2004.12.006_bib55","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/00005053-196509000-00006","article-title":"Addiction Research Center Inventory (ARCI)","volume":"141","author":"Haertzen","year":"1965","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2004.12.006_bib56","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2466\/pr0.1966.18.1.163","article-title":"Development of scales based on patterns of drug effects, using the addiction Research Center Inventory (ARCI)","volume":"18","author":"Haertzen","year":"1966","journal-title":"Psychol Rep"},{"key":"10.1016\/j.biopsych.2004.12.006_bib57","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","article-title":"Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations","volume":"12","author":"Hajos","year":"2000","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1440-1614.2000.00685.x","article-title":"Cannabis use and psychosis","volume":"34","author":"Hall","year":"2000","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0091-3057(90)90028-G","article-title":"Acute and residual effects of marijuana","volume":"37","author":"Heishman","year":"1990","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2004.12.006_bib60","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib61","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1073\/pnas.87.5.1932","article-title":"Cannabinoid receptor localization in brain","volume":"87","author":"Herkenham","year":"1990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopsych.2004.12.006_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF02736775","article-title":"delta 9-Tetrahydrocannabinol increases activity of tyrosine hydroxylase in cultured fetal mesencephalic neurons","volume":"8","author":"Hernandez","year":"1997","journal-title":"J Mol Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib63","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(79)90290-5","article-title":"Pretreatment with delta 1-tetrahydrocannabinol and psychoactive drugs","volume":"59","author":"Hershkowitz","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib64","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1523\/JNEUROSCI.20-07-02470.2000","article-title":"Mechanisms of cannabinoid inhibition of GABA(A) synaptic transmission in the hippocampus","volume":"20","author":"Hoffman","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1600-0447.1988.tb08576.x","article-title":"Cannabis\u20141988","volume":"345","author":"Hollister","year":"1988","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.biopsych.2004.12.006_bib66","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1017\/S1461145798001060","article-title":"Health aspects of cannabis","volume":"1","author":"Hollister","year":"1998","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib67","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF00690920","article-title":"Increased susceptibility to memory intrusions and the Stroop interference effect during acute marijuana intoxication","volume":"91","author":"Hooker","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib68","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.biopsych.2004.12.006_bib69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.cognition.2002.06.001","article-title":"The spatial and temporal signatures of word production components","volume":"92","author":"Indefrey","year":"2004","journal-title":"Cognition"},{"key":"10.1016\/j.biopsych.2004.12.006_bib70","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1192\/bjp.178.2.116","article-title":"Psychiatric effects of cannabis","volume":"178","author":"Johns","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib71","first-page":"655","article-title":"In vitro alteration of the subcellular distribution of 3H-reserpine in the rat forebrain by delta 9-tetrahydrocannabinol","volume":"15","author":"Johnson","year":"1976","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib72","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/BF00428793","article-title":"Pharmacological interaction between cannabidiol and delta 9-tetrahydrocannabinol","volume":"33","author":"Karniol","year":"1973","journal-title":"Psychopharmacologia"},{"key":"10.1016\/j.biopsych.2004.12.006_bib73","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/0014-2999(74)90129-0","article-title":"Cannabidiol interferes with the effects of delta 9-tetrahydrocannabinol in man","volume":"28","author":"Karniol","year":"1974","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib74","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1159\/000136944","article-title":"Effects of delta9-tetrahydrocannabinol and cannabinol in man","volume":"13","author":"Karniol","year":"1975","journal-title":"Pharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib75","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000291514","article-title":"The Positive and Negative Syndrome Scale (PANSS)","volume":"7","author":"Kay","year":"1989","journal-title":"Br J Psychiatry Suppl"},{"key":"10.1016\/j.biopsych.2004.12.006_bib77","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/026988119701100205","article-title":"Dopamine, the prefrontal cortex and schizophrenia","volume":"11","author":"Knable","year":"1997","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib78","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1001\/archpsyc.56.11.1001","article-title":"Gamma frequency-range abnormalities to auditory stimulation in schizophrenia [see comment]","volume":"56","author":"Kwon","year":"1999","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib79","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1097\/00001756-199504190-00011","article-title":"Ketamine activates psychosis and alters limbic blood flow in schizophrenia","volume":"6","author":"Lahti","year":"1995","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2004.12.006_bib80","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0893-133X(94)00131-I","article-title":"Subanesthetic doses of ketamine stimulate psychosis in schizophrenia","volume":"13","author":"Lahti","year":"1995","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib81","first-page":"1182","article-title":"SPECT imaging of striatal dopamine release after amphetamine challenge","volume":"36","author":"Laruelle","year":"1995","journal-title":"J Nucl Med"},{"key":"10.1016\/j.biopsych.2004.12.006_bib82","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1097\/00001756-199906030-00008","article-title":"Elevated endogenous cannabinoids in schizophrenia","volume":"10","author":"Leweke","year":"1999","journal-title":"Neuroreport"},{"key":"10.1016\/j.biopsych.2004.12.006_bib83","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1054\/plef.2001.0351","article-title":"Endocannabinoids in cognition and dependence","volume":"66","author":"Lichtman","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.biopsych.2004.12.006_bib84","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/BF00216006","article-title":"Provocative tests with psychostimulant drugs in schizophrenia","volume":"91","author":"Lieberman","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib85","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/BF00427095","article-title":"Clinical effects and plasma levels of delta 9-tetrahydrocannabinol (delta 9-THC) in heavy and light users of cannabis","volume":"74","author":"Lindgren","year":"1981","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib86","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1001\/archpsyc.1994.03950040017002","article-title":"Cannabis abuse and the course of recent-onset schizophrenic disorders","volume":"51","author":"Linszen","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib87","first-page":"16","article-title":"[Clinical and prognostic characteristics associated with addictive comorbidity in hospitalized psychiatric patients]","volume":"26","author":"Liraud","year":"2000","journal-title":"Encephale"},{"key":"10.1016\/j.biopsych.2004.12.006_bib88","first-page":"160","article-title":"[Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders]","volume":"28","author":"Liraud","year":"2002","journal-title":"Encephale"},{"key":"10.1016\/j.biopsych.2004.12.006_bib89","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0892-0362(01)00165-9","article-title":"Frontal lobe dysfunction in long-term cannabis users","volume":"23","author":"Lundqvist","year":"2001","journal-title":"Neurotoxicol Teratol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib90","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/acps.1980.61.s280.97","article-title":"Amine uptake inhibitors","volume":"280","author":"Maitre","year":"1980","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.biopsych.2004.12.006_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0893-133X(97)00036-5","article-title":"Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics","volume":"17","author":"Malhotra","year":"1997","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0166-2236(96)10029-1","article-title":"The TiPS\/TINS Lecture. Catecholamines: From gene regulation to neuropsychiatric disorders","volume":"19","author":"Mallet","year":"1996","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib93","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/BF00445566","article-title":"Divided attention performance in cannabis users and non-users following alcohol and cannabis separately and in combination","volume":"99","author":"Marks","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib94","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1046\/j.1460-9568.1999.00847.x","article-title":"Expression of the cannabinoid receptor CB1 in distinct neuronal subpopulations in the adult mouse forebrain","volume":"11","author":"Marsicano","year":"1999","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib95","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/346561a0","article-title":"Structure of a cannabinoid receptor and functional expression of the cloned cDNA","volume":"346","author":"Matsuda","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2004.12.006_bib96","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1192\/bjp.181.4.321","article-title":"Use of drugs, alcohol and tobacco by people with schizophrenia","volume":"181","author":"McCreadie","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib97","first-page":"343","article-title":"Approach to functional magnetic resonance imaging of language based on models of language organization","volume":"11","author":"McGraw","year":"2001","journal-title":"Neuroimaging Clin North Am"},{"key":"10.1016\/j.biopsych.2004.12.006_bib98","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0920-9964(94)00053-B","article-title":"Morbid risk of schizophrenia for relatives of patients with cannabis-associated psychosis","volume":"15","author":"McGuire","year":"1995","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.12.006_bib99","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1039\/a703973e","article-title":"From gan-zi-gun-nu to anandamide and 2-arachidonoylglycerol","volume":"16","author":"Mechoulam","year":"1999","journal-title":"Natural Product Rep"},{"key":"10.1016\/j.biopsych.2004.12.006_bib100","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0278-5846(00)00119-6","article-title":"Different mechanisms for dopaminergic excitation induced by opiates and cannabinoids in the rat midbrain","volume":"24","author":"Melis","year":"2000","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib101","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1176\/appi.ajp.161.6.975","article-title":"Placebo-controlled evaluation of four novel compounds for the treatment of schizophrenia and schizoaffective disorder","volume":"161","author":"Meltzer","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib102","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/0091-3057(78)90205-8","article-title":"Marijuana","volume":"9","author":"Miller","year":"1978","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2004.12.006_bib103","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/0006-8993(95)01352-0","article-title":"Roles of dopamine D1 receptors in delta 9-tetrahydrocannabinol-induced expression of Fos protein in the rat brain","volume":"710","author":"Miyamoto","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2004.12.006_bib104","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1006\/nbdi.1998.0224","article-title":"Function of cannabinoid receptors in the neuroendocrine regulation of hormone secretion","volume":"5","author":"Murphy","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.biopsych.2004.12.006_bib105","first-page":"321","article-title":"The effects of cannabis use on the clinical condition of schizophrenics","volume":"67","author":"Negrete","year":"1986","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.biopsych.2004.12.006_bib106","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1017\/S0033291700010278","article-title":"Cannabis affects the severity of schizophrenic symptoms","volume":"16","author":"Negrete","year":"1986","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2004.12.006_bib107","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/clpt.1980.181","article-title":"Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking","volume":"28","author":"Ohlsson","year":"1980","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2004.12.006_bib108","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/sj.mp.4000281","article-title":"Possible role of dopamine D1 receptors in schizophrenia","volume":"2","author":"Okubo","year":"1997","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib109","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/385634a0","article-title":"Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET [comment]","volume":"385","author":"Okubo","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2004.12.006_bib110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0006-8993(02)03797-6","article-title":"Cannabinoid-induced Fos expression within A10 dopaminergic neurons","volume":"963","author":"Patel","year":"2003","journal-title":"Brain Res"},{"key":"10.1016\/j.biopsych.2004.12.006_bib111","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1111\/j.1600-0447.1992.tb01456.x","article-title":"Influence of cannabis abuse on schizophrenic psychopathology","volume":"85","author":"Peralta","year":"1992","journal-title":"Acta Psychiatr Scand"},{"issue":"suppl 3","key":"10.1016\/j.biopsych.2004.12.006_bib112","first-page":"12","article-title":"Cannabis and cannabinoids","volume":"6","author":"Pertwee","year":"1999","journal-title":"Forsch Komplementarmed"},{"key":"10.1016\/j.biopsych.2004.12.006_bib113","first-page":"L1","article-title":"Complex pharmacology of natural cannabinoids","volume":"63","author":"Petitet","year":"1998","journal-title":"Life Sci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib114","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/00005053-197712000-00003","article-title":"Marijuana and memory intrusions","volume":"165","author":"Pfefferbaum","year":"1977","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2004.12.006_bib115","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1046\/j.1460-9568.2002.02019.x","article-title":"Cannabinoids inhibit excitatory inputs to neurons in the shell of the nucleus accumbens","volume":"15","author":"Pistis","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib116","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1046\/j.0953-816x.2001.01612.x","article-title":"Effects of cannabinoids on prefrontal neuronal responses to ventral tegmental area stimulation","volume":"14","author":"Pistis","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib117","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.2042-7158.1992.tb07072.x","article-title":"Some features of Cannabis plants grown in the United Kingdom from seeds of known origin","volume":"44","author":"Pitts","year":"1992","journal-title":"J Pharm Pharmacol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib118","first-page":"63","article-title":"Effects of cannabinoids on catecholamine uptake and release in hypothalamic and striatal synaptosomes","volume":"214","author":"Poddar","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.biopsych.2004.12.006_bib119","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11920-001-0045-7","article-title":"Residual neuropsychologic effects of cannabis","volume":"3","author":"Pope","year":"2001","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.biopsych.2004.12.006_bib120","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1046\/j.1460-9568.1998.00175.x","article-title":"Delta9-tetrahydrocannabinol increases sequence-specific AP-1 DNA-binding activity and Fos-related antigens in the rat brain","volume":"10","author":"Porcella","year":"1998","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib121","first-page":"193","article-title":"[Schizophrenia and addiction","volume":"29","author":"Potvin","year":"2003","journal-title":"Encephale"},{"key":"10.1016\/j.biopsych.2004.12.006_bib122","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0165-3806(90)90280-C","article-title":"Changes in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats","volume":"51","author":"Rodriguez de Fonseca","year":"1990","journal-title":"Brain Res Dev Brain Res"},{"key":"10.1016\/j.biopsych.2004.12.006_bib123","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/0091-3057(92)90526-L","article-title":"Acute effects of delta-9-tetrahydrocannabinol on dopaminergic activity in several rat brain areas","volume":"42","author":"Rodriguez de Fonseca","year":"1992","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2004.12.006_bib124","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0163-7258(02)00253-X","article-title":"The endogenous cannabinoid system and the basal ganglia. Biochemical, pharmacological, and therapeutic aspects","volume":"95","author":"Romero","year":"2002","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.biopsych.2004.12.006_bib125","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00213-002-1348-z","article-title":"Cannabis is more than simply delta(9)-tetrahydrocannabinol [comment]","volume":"165","author":"Russo","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib126","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0091-3057(89)90521-2","article-title":"Delta 9-tetrahydrocannabinol facilitates striatal dopaminergic transmission","volume":"33","author":"Sakurai-Yamashita","year":"1989","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2004.12.006_bib127","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/00005053-198711000-00001","article-title":"A review of psychoactive substance use and abuse in schizophrenia. Patterns of drug choice","volume":"175","author":"Schneier","year":"1987","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.biopsych.2004.12.006_bib128","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-0447.1970.tb02066.x","article-title":"A rating scale for extrapyramidal side effects","volume":"212","author":"Simpson","year":"1970","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/j.biopsych.2004.12.006_bib129","series-title":"Cannabis and Cognitive Functioning","author":"Solowij","year":"1998"},{"key":"10.1016\/j.biopsych.2004.12.006_bib130","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/0091-3057(91)90382-C","article-title":"Effects of long-term cannabis use on selective attention","volume":"40","author":"Solowij","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.biopsych.2004.12.006_bib131","doi-asserted-by":"crossref","first-page":"7407","DOI":"10.1523\/JNEUROSCI.23-19-07407.2003","article-title":"Abnormal neural synchrony in schizophrenia","volume":"23","author":"Spencer","year":"2003","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib132","series-title":"Structured Clinical Interview for DSM-III-R-Patient Edition (SCID-P, Version 1.0)","author":"Spitzer","year":"1990"},{"key":"10.1016\/j.biopsych.2004.12.006_bib133","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s00127-004-0771-3","article-title":"Is the excess risk of psychosis-like experiences in urban areas attributable to altered cognitive development?","volume":"39","author":"Stefanis","year":"2004","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib134","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1152\/jn.1999.82.3.1286","article-title":"Mechanisms of cannabinoid-receptor-mediated inhibition of synaptic transmission in cultured hippocampal pyramidal neurons","volume":"82","author":"Sullivan","year":"1999","journal-title":"J Neurophysiol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib135","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","article-title":"Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib136","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism [comment]","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2004.12.006_bib137","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/383621a0","article-title":"A mechanism for generation of long-range synchronous fast oscillations in the cortex","volume":"383","author":"Traub","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2004.12.006_bib138","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S0306-4522(97)00436-3","article-title":"Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system","volume":"83","author":"Tsou","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2004.12.006_bib139","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S0306-4522(99)00086-X","article-title":"Cannabinoid CB1 receptors are localized primarily on cholecystokinin-containing GABAergic interneurons in the rat hippocampal formation","volume":"93","author":"Tsou","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.biopsych.2004.12.006_bib140","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1021\/np50008a001","article-title":"Constituents of Cannabis sativa L. XVII. A review of the natural constituents","volume":"43","author":"Turner","year":"1980","journal-title":"J Natural Products"},{"key":"10.1016\/j.biopsych.2004.12.006_bib141","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/sj.mp.4001029","article-title":"CNR1, central cannabinoid receptor gene, associated with susceptibility to hebephrenic schizophrenia","volume":"7","author":"Ujike","year":"2002","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib142","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00127-004-0713-0","article-title":"Substance misuse at presentation to an early psychosis program","volume":"39","author":"Van Mastrigt","year":"2004","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib143","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwf043","article-title":"Cannabis use and psychosis","volume":"156","author":"van Os","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biopsych.2004.12.006_bib144","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0033291702006384","article-title":"Effects of cannabis and psychosis vulnerability in daily life","volume":"33","author":"Verdoux","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.biopsych.2004.12.006_bib145","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0920-9964(01)00401-7","article-title":"Cannabis use and dimensions of psychosis in a nonclinical population of female subjects","volume":"59","author":"Verdoux","year":"2003","journal-title":"Schizophr Res"},{"key":"10.1016\/j.biopsych.2004.12.006_bib146","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/sj.npp.1300316","article-title":"Repeated, intermittent delta(9)-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention","volume":"29","author":"Verrico","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib147","first-page":"47","article-title":"Metabolic studies of drugs of abuse","volume":"105","author":"Volkow","year":"1991","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.biopsych.2004.12.006_bib148","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0925-4927(96)02817-X","article-title":"Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication","volume":"67","author":"Volkow","year":"1996","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.biopsych.2004.12.006_bib149","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1523\/JNEUROSCI.16-20-06402.1996","article-title":"Gamma oscillation by synaptic inhibition in a hippocampal interneuronal network model","volume":"16","author":"Wang","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.biopsych.2004.12.006_bib150","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S0006-3223(98)00331-X","article-title":"Cell biology of the hippocampal formation in schizophrenia","volume":"45","author":"Weinberger","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib151","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/373612a0","article-title":"Synchronized oscillations in interneuron networks driven by metabotropic glutamate receptor activation [see comment]","volume":"373","author":"Whittington","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.biopsych.2004.12.006_bib152","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.biopsych.2004.12.006_bib153","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0893-133X(98)00112-2","article-title":"Developing a neuronal model for the pathophysiology of schizophrenia based on the nature of electrophysiological actions of dopamine in the prefrontal cortex","volume":"21","author":"Yang","year":"1999","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib154","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/bmj.325.7374.1199","article-title":"Self reported cannabis use as a risk factor for schizophrenia in Swedish conscripts of 1969","volume":"325","author":"Zammit","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.biopsych.2004.12.006_bib155","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pnpbp.2003.11.005","article-title":"Selective antagonist [3H]SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia","volume":"28","author":"Zavitsanou","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib156","first-page":"485","article-title":"Antipsychotic effect of cannabidiol [letter]","volume":"56","author":"Zuardi","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.biopsych.2004.12.006_bib157","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF02244189","article-title":"Effects of cannabidiol in animal models predictive of antipsychotic activity","volume":"104","author":"Zuardi","year":"1991","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.biopsych.2004.12.006_bib158","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/BF00432554","article-title":"Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects","volume":"76","author":"Zuardi","year":"1982","journal-title":"Psychopharmacology"}],"container-title":["Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304013101?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006322304013101?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,22]],"date-time":"2024-12-22T17:01:06Z","timestamp":1734886866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006322304013101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":158,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0006322304013101"],"URL":"https:\/\/doi.org\/10.1016\/j.biopsych.2004.12.006","relation":{},"ISSN":["0006-3223"],"issn-type":[{"value":"0006-3223","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}